A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously ...

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.

Adding pembrolizumab to CCRT improved survival outcomes in patients with high-risk, locally advanced cervical cancer.

New trends data show significant reduction in the incidence of precancerous lesions in young women since advent of vaccine.

Wanting to be on the safe side, Lauren went to the GP in August. She was examined by a doctor who didn't believe she had ...

It could have changed the course of her life, but instead of looking back with regret, Alicia Hilderley is celebrating a new ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...

Only 45.5% of patients completed guideline-concordant surveillance within 30 months after treatment for high-grade cervical ...

Experts say it’s an opportunity to help address barriers for people such as racialized immigrants and refugees, Indigenous ...

A University of Rochester Medical Center study showed that downtime in the emergency room can have a potential upside for ...

Cervical cancer remains one of the most preventable cancers, yet it continues to pose a significant health threat to women in ...